We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Certain Optic Cells Export Their Damaged Mitochondria for Destruction Elsewhere

By LabMedica International staff writers
Posted on 25 Jun 2014
Print article
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
Image: Pictured is mouse optic nerve and retina, responsible for relaying information from the eye to the brain. The tissue has been fluorescently stained to reveal the distribution of astrocytes (yellow), retinal ganglion cell axons (purple), myelin (green) and nuclei (cyan). Retinal ganglion cell axons transfer mitochondria to adjacent astrocytes in the optic nerve head behind the retina. Astrocytes degrade the mitochondria in a process called transmitophagy (Photo courtesy of the University of California, San Diego).
A recent paper revealed that certain cells in the eye transfer damaged mitochondria to neighboring cells for destruction (mitophagy) and recycling.

Mitophagy is considered a subset of the process known as autophagy, by which damaged organelles are enwrapped and delivered to lysosomes for degradation. As such, it was always assumed that a cell degraded its own mitochondria. However, results presented in the June 16, 2014, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) by investigators at the University of California, San Diego (USA) and Johns Hopkins University (Baltimore, MD, USA) suggest that this assumption may be incorrect.

The investigators used advanced electron microscopy and molecular staining techniques to show that in the optic nerve head, large numbers of mitochondria were shed from neurons to be degraded by the lysosomes of adjoining glial cells. This investigation had been prompted by findings from a glaucoma mouse model that protein products from the retina were accumulating in the optic nerve head just behind the eye.

In the study, a virally introduced tandem fluorophore protein reporter of acidified mitochondria was introduced into mice retinal ganglion cells. The reporter revealed that acidified axonal mitochondria originating from the retinal ganglion cells became associated with lysosomes within columns of astrocytes in the optic nerve head. According to this reporter, a greater proportion of retinal ganglion cell mitochondria were degraded at the optic nerve head than in the ganglions. The investigators coined the term "transmitophagy" to describe this phenomenon.

“It does call into question the conventional assumption that cells necessarily degrade their own organelles. We do not yet know how generalized this process is throughout the brain, but our work suggests it is probably widespread,” said co-senior author Dr. Mark H. Ellisman, professor of neurosciences at the University of California, San Diego. “Mitochondria play prominent roles in the health of axons, which are fundamental to connecting neurons and transmitting information. It should be a priority to further explore what happens in transmitophagy and whether defects in this phenomenon contribute to neuronal dysfunction or disease.”

“The discovery of a standard process for transfer of trash from neuron to glia will most likely be very important to understanding age-related declines in function of the brain and neurodegenerative or metabolic disorders,” said co-senior author Dr. Nicholas Marsh-Armstrong, assistant professor of ophthalmology and neuroscience at Johns Hopkins University. “We expect the impact to be significant in other areas of biomedicine as well.”

Related Links:

University of California, San Diego
Johns Hopkins University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.